Literature DB >> 18280559

Indicators of sexual and somatic development and adolescent body size in relation to prostate cancer risk: results from a case-control study.

Maddalena Barba1, Irene Terrenato, Holger J Schünemann, Barbara Fuhrman, Francesca Sperati, Barbara Teter, Michele Gallucci, Alberto D'Amato, Paola Muti.   

Abstract

OBJECTIVES: To examine the relationship between the indicators of sexual and somatic development (ie, age at first shaving and maximal shoe size) and adolescent anthropometric characteristics (ie, body size at age 10 to 13 years) and prostate cancer risk.
METHODS: We analyzed the data from a population-based case-control study in Erie and Niagara Counties, New York. The participants were 64 men with incident, primary, histologically confirmed, clinically apparent (Stage B and greater) prostate cancer and 218 controls, who had been frequency matched by age and residential area. Information regarding the variables of interest was self-reported. We compared the adjusted mean age at first shaving and age at maximal shoe size and calculated the odds of body size at ages 10 to 13 years using logistic regression models.
RESULTS: The patients showed no evidence of older age at first shaving (adjusted mean, 18.0 versus 17.8 years, P = 0.46) or significant evidence of older age at the maximal shoe size (20.1 versus 17.6 years, P <0.05). The participants who defined themselves as being as heavy as or heavier than their peers at age 10 to 13 years showed a decreased prostate cancer risk compared with participants who were thinner than their peers (odds ratio 0.36, 95% confidence interval 0.15 to 0.83; and odds ratio 0.38, 95% confidence interval 0.17 to 0.87, respectively).
CONCLUSIONS: Our results support a role for the indicators of somatic development and adolescent body size in predicting prostate cancer risk, suggesting that risk determinants operating early in life affect men's subsequent prostate cancer risk.

Entities:  

Mesh:

Year:  2008        PMID: 18280559     DOI: 10.1016/j.urology.2007.09.065

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  9 in total

1.  Body size across the life course and prostate cancer in the Health Professionals Follow-up Study.

Authors:  Elisabeth Möller; Kathryn M Wilson; Julie L Batista; Lorelei A Mucci; Katarina Bälter; Edward Giovannucci
Journal:  Int J Cancer       Date:  2015-09-23       Impact factor: 7.396

Review 2.  Prostate cancer: is it time to expand the research focus to early-life exposures?

Authors:  Siobhan Sutcliffe; Graham A Colditz
Journal:  Nat Rev Cancer       Date:  2013-01-31       Impact factor: 60.716

3.  Risk of prostate cancer in a population-based cohort of men with coeliac disease.

Authors:  J F Ludvigsson; K Fall; S Montgomery
Journal:  Br J Cancer       Date:  2011-12-01       Impact factor: 7.640

4.  Childhood body mass index and the risk of prostate cancer in adult men.

Authors:  J Aarestrup; M Gamborg; M B Cook; T I A Sørensen; J L Baker
Journal:  Br J Cancer       Date:  2014-05-27       Impact factor: 7.640

Review 5.  Racial differences in prostate cancer: does timing of puberty play a role?

Authors:  Jinhee Hur; Edward Giovannucci
Journal:  Br J Cancer       Date:  2020-05-22       Impact factor: 7.640

6.  Impact of early hypothalamic-pituitary-gonadal axis maturation on prostate cancer: cross-sectional analysis of a Veterans affairs cohort.

Authors:  Rimaz M Khadir; Rashid K Sayyid; Brian Matthews; Sherita A King; Martha K Terris
Journal:  Transl Androl Urol       Date:  2021-08

Review 7.  Adult Consequences of Self-Limited Delayed Puberty.

Authors:  Jia Zhu; Yee-Ming Chan
Journal:  Pediatrics       Date:  2017-05-18       Impact factor: 7.124

8.  Urinary estrogen metabolites and prostate cancer: a case-control study and meta-analysis.

Authors:  Maddalena Barba; Li Yang; Holger J Schünemann; Francesca Sperati; Sara Grioni; Saverio Stranges; Kim C Westerlind; Giovanni Blandino; Michele Gallucci; Rossella Lauria; Luca Malorni; Paola Muti
Journal:  J Exp Clin Cancer Res       Date:  2009-10-08

9.  Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort.

Authors:  Carolina Bonilla; Sarah J Lewis; Richard M Martin; Jenny L Donovan; Freddie C Hamdy; David E Neal; Rosalind Eeles; Doug Easton; Zsofia Kote-Jarai; Ali Amin Al Olama; Sara Benlloch; Kenneth Muir; Graham G Giles; Fredrik Wiklund; Henrik Gronberg; Christopher A Haiman; Johanna Schleutker; Børge G Nordestgaard; Ruth C Travis; Nora Pashayan; Kay-Tee Khaw; Janet L Stanford; William J Blot; Stephen Thibodeau; Christiane Maier; Adam S Kibel; Cezary Cybulski; Lisa Cannon-Albright; Hermann Brenner; Jong Park; Radka Kaneva; Jyotsna Batra; Manuel R Teixeira; Hardev Pandha; Mark Lathrop; George Davey Smith
Journal:  BMC Med       Date:  2016-04-04       Impact factor: 8.775

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.